|
EXOG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.48040000042182E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.08849999999705E-05 |
| Normal-vs-Stage2 |
5.523700E-03 |
| Normal-vs-Stage3 |
1.02729999951201E-07 |
| Normal-vs-Stage4 |
6.601300E-04 |
| Stage1-vs-Stage2 |
8.534000E-01 |
| Stage1-vs-Stage3 |
3.435600E-02 |
| Stage1-vs-Stage4 |
3.085000E-01 |
| Stage2-vs-Stage3 |
1.161220E-01 |
| Stage2-vs-Stage4 |
3.342200E-01 |
| Stage3-vs-Stage4 |
7.516000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.49739999475574E-08 |
| Normal-vs-AfricanAmerican |
2.036400E-04 |
| Normal-vs-Asian |
8.164800E-01 |
| Caucasian-vs-AfricanAmerican |
7.455200E-01 |
| Caucasian-vs-Asian |
2.049900E-04 |
| AfricanAmerican-vs-Asian |
6.982200E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.419010E-04 |
| Normal-vs-Female |
3.19980000051956E-07 |
| Male-vs-Female |
6.820800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.27959999999206E-05 |
| Normal-vs-Age(41-60Yrs) |
2.19859999994743E-06 |
| Normal-vs-Age(61-80Yrs) |
1.168820E-04 |
| Normal-vs-Age(81-100Yrs) |
1.719440E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.193400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.258800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.612200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.859200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.381000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.666600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.81339999999875E-05 |
| Classical-VS-Follicular |
5.086000E-01 |
| Classical-VS-Other |
6.916000E-01 |
| Classical-VS-Normal |
2.154600E-04 |
| Tall-VS-Follicular |
2.464700E-03 |
| Tall-VS-Other |
3.359000E-01 |
| Tall-VS-Normal |
4.55170001689709E-09 |
| Follicular-VS-Other |
8.705600E-01 |
| Follicular-VS-Normal |
4.792700E-04 |
| Other-VS-Normal |
5.938300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65309999999863E-06 |
| Normal-vs-N1 |
1.612350E-02 |
| N0-vs-N1 |
6.778600E-01 |
|
|
